| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
| Company Name: |
cjbscvictory |
| Tel: |
13348960310 13348960310 |
| Email: |
3003867561@qq.com |
CP-409092 manufacturers
- CP-409092
-
- $2380.00
-
2026-05-11
- CAS:194098-25-4
- Purity:
- Supply Ability: 10g
- CP-409092
-
- $2380.00
-
2025-07-19
- CAS:194098-25-4
- Purity:
- Supply Ability: 10g
|
| | CP-409092 Basic information |
| Product Name: | CP-409092 | | Synonyms: | CP-409092;CP 409092,CP409092;1H-Indole-3-carboxamide, 4,5,6,7-tetrahydro-N-[4-[(methylamino)methyl]phenyl]-4-oxo- | | CAS: | 194098-25-4 | | MF: | C17H19N3O2 | | MW: | 297.35 | | EINECS: | | | Product Categories: | | | Mol File: | 194098-25-4.mol |  |
| | CP-409092 Chemical Properties |
| Boiling point | 475.0±45.0 °C(Predicted) | | density | 1.283±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: 41.67 mg/mL (140.14 mM) | | pka | 13.05±0.70(Predicted) |
| | CP-409092 Usage And Synthesis |
| Uses | CP-409092 is a partial agonist of GABAA receptor, with anti-anxiety activity[1]. | | in vivo | The pharmacokinetics of CP-409,092 following single intravenous and oral doses of 4 and 15 mg/kg, respectively, are characterized by high clearance of 169+ or -18 mL/min/kg, a volume of distribution of 8.99+ or -1.46 L/kg, and an oral bioavailability of 2.9%+ or -3%. Following oral administration of 100 mg/kg [14C]CP-409,092, the total recovery is 89.1%+ or -3.2% for male rats and 89.3%+ or -0.58% for female rats[1]. | | References | [1] Kamel A, et al. Metabolism, pharmacokinetics and excretion of the GABA(A) receptor partial agonist [(14)C]CP-409,092 in rats. Xenobiotica. 2010 Jun;40(6):400-14. DOI:10.3109/00498251003710269 |
| | CP-409092 Preparation Products And Raw materials |
|